Arnica Montana Nartex

Arnica Montana, Hamamelis Virginica


Nartex Laboratorios Homeopaticos Sa De Cv
Human Otc Drug
NDC 34666-007
Arnica Montana Nartex also known as Arnica Montana, Hamamelis Virginica is a human otc drug labeled by 'Nartex Laboratorios Homeopaticos Sa De Cv'. National Drug Code (NDC) number for Arnica Montana Nartex is 34666-007. This drug is available in dosage form of Ointment. The names of the active, medicinal ingredients in Arnica Montana Nartex drug includes Arnica Montana - 1.66 g/28g Hamamelis Virginiana Leaf - 1.66 g/28g . The currest status of Arnica Montana Nartex drug is Active.

Drug Information:

Drug NDC: 34666-007
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Arnica Montana Nartex
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Arnica Montana, Hamamelis Virginica
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Nartex Laboratorios Homeopaticos Sa De Cv
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Ointment
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARNICA MONTANA - 1.66 g/28g
HAMAMELIS VIRGINIANA LEAF - 1.66 g/28g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 23 Dec, 2010
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 23 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:NARTEX LABORATORIOS HOMEOPATICOS SA DE CV
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:O80TY208ZW
T07U1161SV
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
34666-007-1616 g in 1 CONTAINER (34666-007-16)23 Dec, 2010N/ANo
34666-007-2828 g in 1 CONTAINER (34666-007-28)23 Dec, 2010N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Anti-inflammatory, pain reliever

Product Elements:

Arnica montana nartex arnica montana, hamamelis virginica glycerin lanolin sodium benzoate petrolatum water arnica montana arnica montana hamamelis virginiana leaf hamamelis virginiana leaf

Indications and Usage:

For the temporary relief of sore muscles bruises sprains as per homeopathic materia medica

Warnings:

Warnings: for external use only.

Do Not Use:

Warnings: for external use only.

Dosage and Administration:

Adults and children over 2 years of age and older: apply generously rubbing into the affected area reapply if needed children under 2 years of age: consult a physician

Stop Use:

Stop use and ask a doctor if: condition worsens if symptoms persist for more than 7 days or clear up and occur again within a few days rash develops

Package Label Principal Display Panel:

Homeopathic relief for sore muscles, bruises and sprains. arnica montana nartex carton

Further Questions:

Questions or comments? p.o. box 1261, downey ca 90240 www.nartexlabs.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.